[18F]FAPI-04与[18F]FDG PET/CT检测腹膜癌变的效用比较研究
本研究纳入71例疑似腹膜恶性肿瘤患者,均在7天内完成[18F]FAPI-04与[18F]FDG PET/CT显像,比较两种示踪剂的检出率、诊断准确率、半定量参数、腹膜癌指数(PCI)评分及肿瘤标志物。结果显示[18F]FAPI-04 PET/CT的敏感度和准确率高于[18F]FDG PET/CT(敏感度92.50% vs. 72.50%,p=0.003;准确率91.55% vs. 80.28%,p<0.001),尤其在胃癌患者中;[18F]FAPI-04的SUVmax、TBR-L、TBR-A及PCI评分均显著高于[18F]FDG(均p<0.05)。结论认为[18F]FAPI-04 PET/CT在腹膜癌变评估中优于[18F]FDG PET/CT,尤其对胃癌患者,并可能用于腹膜癌变评估,尤其是FAPI-PCI。
要点
- [18F]FAPI-04 PET/CT诊断腹膜癌变的敏感度92.50%、准确率91.55%,均高于[18F]FDG PET/CT的72.50%和80.28%。
- [18F]FAPI-04 PET/CT的SUVmax、TBR-L、TBR-A及PCI评分均显著高于[18F]FDG PET/CT(均p<0.05)。
- 在[18F]FAPI-04 PET/CT组中,高水平组的PCI评分、TBR-L、TBR-A、TBR-M及SUVmax均高于低水平组(均p<0.05)。
核心结论
- [18F]FAPI-04 PET/CT在腹膜癌变评估中优于[18F]FDG PET/CT,尤其在胃癌患者中;[18F]FAPI-04 PET/CT可能用于腹膜癌变评估,尤其是FAPI-PCI。
研究设计与样本
- 本研究纳入71例疑似腹膜恶性肿瘤患者,所有参与者均在7天内完成[18F]FAPI-04和[18F]FDG PET/CT显像,比较两种示踪剂的检出率、诊断准确率、半定量参数、腹膜癌指数(PCI)评分及肿瘤标志物。
关键影像表现/征象
- 71例中40例诊断为腹膜癌变,31例为真阴性患者。
- [18F]FAPI-04 PET/CT的SUVmax、肿瘤与肝脏背景比值(TBR-L)、肿瘤与降主动脉比值(TBR-A)及PCI评分均显著高于[18F]FDG PET/CT(均p<0.05)。
- 在[18F]FAPI-04 PET/CT组中,高水平组的PCI评分、TBR-L、TBR-A、TBR-M及SUVmax均高于低水平组(均p<0.05)。
诊断标准与关键数值
- [18F]FAPI-04 PET/CT诊断腹膜癌变的敏感度为92.50%,[18F]FDG PET/CT为72.50%(p=0.003)。
- [18F]FAPI-04 PET/CT诊断腹膜癌变的准确率为91.55%,[18F]FDG PET/CT为80.28%(p<0.001)。
- 癌抗原125(CA 125)水平与[18F]FAPI-04及[18F]FDG PET/CT的PCI均强相关。
临床应用与阅片要点
- [18F]FAPI-04 PET/CT在腹膜癌变评估中优于[18F]FDG PET/CT,尤其在胃癌患者中。
- [18F]FAPI-04 PET/CT可能用于腹膜癌变评估,尤其是FAPI-PCI。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: In this study, we aimed to compared the performance of [18F]FAPI-04 and [18F]fluorodeoxyglucose (FDG) positron emission tomography/computer tomography (PET/CT) in the evaluation of peritoneal carcinomatosis.
MATERIALS AND METHODS: 71 patients with suspected peritoneal malignancies were enrolled in our study. All the participants underwent both [18F]FAPI-04 and [18F]FDG PET/CT imaging within 7 days. The detection rates, diagnostic accuracies, semiquantitative parameters of the tracers, peritoneal cancer index (PCI) scores, and tumor markers were evaluated and compared.
RESULTS: Among the 71 patients, 40 patients were diagnosed with peritoneal carcinomatosis, and 31 were true-negative patients. The sensitivity and accuracy of [18F]FAPI-04 PET/CT were higher than those of [18F]FDG PET/CT (sensitivity: 92.50% vs. 72.50%, p=0.003; accuracy: 91.55% vs. 80.28%, p<0.001), particularly in patients with gastric cancer. The SUVmax, tumor-to-liver background ratio (TBR-L), tumor-to-descending aorta ratio (TBR-A), and PCI score were significantly higher for [18F]FAPI-04 PET/CT than [18F]FDG PET/CT (all p<0.05). In the [18F]FAPI-04 PET/CT group, the PCI score, TBR-L, TBR-A, TBR-M and SUVmax were higher in the high level group than the low level group (all p<0.05). The carbohydrate antigen 125 (CA 125) levels were strongly correlated with the PCI of both [18F]FAPI-04 and [18F]FDG PET/CT.
CONCLUSION: [18F]FAPI-04 PET/CT outperformed [18F]FDG PET/CT in the evaluation of peritoneal carcinomatosis, particularly in patients with gastric cancer. Furthermore, [18F]FAPI-04 PET/CT may be used for the assessment of peritoneal carcinomatosis in patients, especially FAPI-PCI.
引用
- Jiang C, Zheng K, Zhang Y, et al. Usefulness of [18F]FAPI-04 and [18F]FDG PET/CT for the Detection of Peritoneal Carcinomatosis: A Comparative Study. Acad Radiol. 2025. PMID: 40541551. doi:10.1016/j.acra.2025.05.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。